A Major Role for TPPII in Trimming Proteasomal Degradation Products for MHC Class I Antigen Presentation

Total Page:16

File Type:pdf, Size:1020Kb

A Major Role for TPPII in Trimming Proteasomal Degradation Products for MHC Class I Antigen Presentation CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Immunity, Vol. 20, 495–506, April, 2004, Copyright 2004 by Cell Press A Major Role for TPPII in Trimming Proteasomal Degradation Products for MHC Class I Antigen Presentation Eric Reits,1 Joost Neijssen,1 Carla Herberts,1 subsequently degraded (Koopmann et al., 2000; Roelse Willemien Benckhuijsen,2 Lennert Janssen,1 et al., 1994). MHC class I molecules usually bind pep- Jan Wouter Drijfhout,2 and Jacques Neefjes1,* tides of nine amino acids with appropriate anchor resi- 1Division of Tumor Biology dues (Rammensee et al., 1993). The TAP transporter The Netherlands Cancer Institute also prefers to translocate peptides of around nine Plesmanlaan 121 amino acids (Momburg et al., 1994a), although substrate 1066 CX Amsterdam peptides up to 40 amino acids can be translocated into The Netherlands the ER lumen as well (Koopmann et al., 1996). TAP shows 2 Department of Immunohematology minor specificity for peptide sequences (Momburg et al., and Blood Transfusion 1994b), which is not unexpected since it has to provide Leiden University Medical Center different class I molecules with peptide epitopes. 2300 RC Leiden In vitro experiments suggest that most peptides gen- The Netherlands erated by the proteasome will probably have an incor- rect size for direct class I loading (Kisselev et al., 1999; Toes et al., 2001). N-terminal extended epitopes can be Summary trimmed to the correct size for MHC class I binding by cytoplasmic and ER luminal aminopeptidases, but most Intracellular proteins are degraded by the proteasome, peptides will be completely recycled into free amino and resulting peptides surviving cytoplasmic peptidase acids (Reits et al., 2003). Several cytoplasmic amino- activity can be presented by MHC class I molecules. and endopeptidases have been identified, including leu- Here, we show that intracellular aminopeptidases de- cine aminopeptidase (LAP) (Beninga et al., 1998), tripep- grade peptides within seconds, almost irrespectively tidyl peptidase II (TPPII) (Geier et al., 1999; Tomkinson, of amino acid sequence. N- but not C-terminal exten- 1999), thimet oligopeptidase (TOP) (Mo et al., 1999), sion increases the half-life of peptides until they are bleomycin hydrolase (BH) (Bromme et al., 1996; Stoltze 15 amino acids long. Beyond 15 amino acids, peptides et al., 2000), and puromycin-sensitive aminopeptidase are exclusively trimmed by the peptidase TPPII, which (PSA) (Johnson and Hersh, 1990; Stoltze et al., 2000). displays both exo- and endopeptidase activity. Sur- Overexpression of LAP (Reits et al., 2003) or TOP (York prisingly, most proteasomal degradation products are et al., 2003) reduces class I expression, suggesting a handled by TPPII before presentation by MHC class I role for these peptidases in trimming peptides for MHC molecules. We define three distinct proteolytic activi- class I molecules. In addition, the ER-associated amino- ties during antigen processing in vivo. Proteasome- peptidase is also involved in peptide generation for MHC generated peptides relevant for antigen presentation class I molecules but also their destruction (Serwold et are mostly 15 amino acids or longer. These require al., 2002; York et al., 2002). Since cells lack cytoplasmic TPPII activity for further trimming before becoming carboxypeptidase activities (Reits et al., 2003), the pro- substrates for other peptidases and MHC class I. The teasome should generate the correct C terminus of pep- heterogeneous pool of aminopeptidases will process tides for the MHC class I peptide binding groove (Cascio et al., 2001), unless endopeptidases exist. TPPII appears TPPII products into MHC class I peptides and beyond. to be essential for the generation of a particular HIV epitope (Seifert et al., 2003) and exhibits endopeptidase Introduction activity in vitro (Geier et al., 1999; Seifert et al., 2003). These data suggest that various peptidases modify the The proteasome is the dominant cellular protease de- pool of class I peptides. Although there may be special- grading intracellular proteins (Kloetzel, 2001; Rock et ization in location, substrate specificity, and amounts, al., 1994), including many newly synthesized proteins their collective activity may determine the outcome of (Reits et al., 2000; Schubert et al., 2000). Only a small a MHC class I response, since more than 99% of the fraction of these peptides is translocated by the trans- peptides are destroyed by peptidases (Princiotta et al., porter associated with antigen processing (TAP) into the 2003; Reits et al., 2003). The few peptides escaping lumen of the endoplasmic reticulum (ER), where they peptidase activity may represent a small pool of particu- can bind newly synthesized MHC class I molecules (re- lar peptides that resist proteases due to amino acid viewed by Yewdell et al., 2003). The vast majority of sequence and peptide length. Alternatively, a nonselec- generated peptides are however degraded by cyto- tive process that degrades peptides at random may plasmic peptidases before being able to interact with be operational with some inefficiency in the form of TAP (Fruci et al., 2003; Reits et al., 2003). In addition, escaping peptides. This is, however, hard to determine peptides can be trimmed by the ER-associated amino- on the basis of the few known in vitro-determined pepti- peptidase ERAAP or ERAP1 before binding to MHC dase specificities. class I molecules (Saric et al., 2002; Serwold et al., 2002; Here, we have studied the specificity of the collective York et al., 2002), while other peptides are translocated cytoplasmic peptidase activities using internally quenched back into the cytoplasm by the Sec61 complex and peptides introduced into living cells. Peptides are rapidly degraded by aminopeptidases without dramatic se- *Correspondence: [email protected] quence specificity. N-terminal but not C-terminal exten- Immunity 496 Figure 1. Detecting Peptidase Activity in Liv- ing Cells (A) Principle of detecting peptidase activity. Internally quenched peptides are injected in cells. The emission of the fluorescein side chain (F) is absorbed by the quencher Dabcyl moiety (Q). Emission of fluorescein can only be detected when the two groups are spa- tially separated after degradation. (B) Representative degradation curves of two peptides in vivo. Model peptide T[K-Dabcyl]- NKTER[C-Fluorescein]Y (black line) was mi- croinjected (indicated by the arrow) in a single melanoma cell (Mel JuSo), and the appear- ance of fluorescence was monitored at 520 nm. This experiment was repeated with the same peptide with an N-terminal D amino acid (D-T)[K-Dabcyl]NKTER[C-Fluorescein]Y (gray line). The figure shows a merge of the two experiments. Fluorescence appears im- mediately after introduction in the cell and goes to completion. sion increases the half-life of the reporter peptide, which the 9-mer peptide was no substrate for proteasomes is in line with observations that carboxy peptidase activ- (data not shown). This agrees with the observation that ity is absent in the cytoplasm. Beyond 15 amino acids, N-terminally protected peptides were stable in vivo. Ap- peptides become the exclusive substrate for TPPII that parently, small peptides are digested in the cytoplasm removes N-terminal sequences, including nine potential exclusively by aminopeptidases and not by carboxy or amino acid epitopes. However, epitopes located at the endopeptidases (Reits et al., 2003). C terminus of these larger peptides are presented less efficiently suggesting that TPPII can generate but also Sequence Specificity of the Intracellular destroy epitopes. We show that TPPII plays an important Peptidase Pool role in antigen processing, as most proteasomal prod- Some aminopeptidases like LAP have defined substrate ucts require further processing by TPPII for MHC class specificities (Turzynski and Mentlein, 1990). Variation in I presentation. As a consequence, peptide generation the amino acid sequence of the reporter peptide may for MHC class I is severely hampered when TPPII activity therefore affect the degradation rate in vivo. This is im- is inhibited. portant since an increased peptide half-life should theo- retically correlate with a better chance to reach the ER Results lumen, resulting in an improved class I presentation. To examine whether the cytoplasmic peptidases collec- Aminopeptidases Degrade Peptides In Vivo tively show sequence selectivity, we systematically var- An internally quenched 9-mer peptide was used to de- ied amino acids positioned at the first, second, third, tect peptidase activity in vivo. The quenched reporter or last position within an internally quenched reporter peptide (T[K-Dabcyl]NKTER[C-Fluorescein]Y) contains peptide sequence (Figures 2A–2D). The variable amino a quenching Dabcyl group and a fluorescein group cou- acids (indicated as “X”) were representatives of every pled to amino acid two and eight, respectively. The chemical group of amino acids. With the exception of quencher efficiently absorbs emission of the nearby flu- the third amino acid position, the variable amino acids orescein group, and fluorescence will only be detected were positioned outside the quencher-fluorophore box when amino acids two and eight are separated in space (indicated by “K” and “C”). Peptide degradation always as the result of peptidase activity (Figure 1A). As shown started immediately after its introduction in living cells before (Reits et al., 2003), fluorescence appeared almost by microinjection
Recommended publications
  • The Global Architecture Shaping the Heterogeneity and Tissue-Dependency of the MHC Class I Immunopeptidome Is Evolutionarily Conserved
    bioRxiv preprint doi: https://doi.org/10.1101/2020.09.28.317750; this version posted September 29, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The Global Architecture Shaping the Heterogeneity and Tissue-Dependency of the MHC Class I Immunopeptidome is Evolutionarily Conserved Authors Peter Kubiniok†1, Ana Marcu†2,3, Leon Bichmann†2,4, Leon Kuchenbecker4, Heiko Schuster1,5, David Hamelin1, Jérome Despault1, Kevin Kovalchik1, Laura Wessling1, Oliver Kohlbacher4,7,8,9,10 Stefan Stevanovic2,3,6, Hans-Georg Rammensee2,3,6, Marian C. Neidert11, Isabelle Sirois1, Etienne Caron1,12* Affiliations *Corresponding and Leading author: Etienne Caron ([email protected]) †Equal contribution to this work 1CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada 2Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Baden-Württemberg, 72076, Germany. 3Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Baden-Württemberg, 72076, Germany. 4Applied Bioinformatics, Dept. of Computer Science, University of Tübingen, Tübingen, Baden- Württemberg, 72074, Germany. 5Immatics Biotechnologies GmbH, Tübingen, 72076, Baden-Württemberg, Germany. 6DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Baden- Württemberg, 72076, Germany. 7Institute for Bioinformatics and Medical Informatics,
    [Show full text]
  • Characterisation of Aspergillus Niger Prolyl Aminopeptidase
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Wageningen University & Research Publications Mol Gen Genomics (2005) 272: 673–679 DOI 10.1007/s00438-004-1094-5 ORIGINAL PAPER Danie¨lle E. J. W. Basten Æ Antoine P. H. A. Moers Albert J. J. van. Ooyen Æ Peter J. Schaap Characterisation of Aspergillus niger prolyl aminopeptidase Received: 29 April 2004 / Accepted: 16 November 2004 / Published online: 15 January 2005 Ó Springer-Verlag 2005 Abstract We have cloned a gene (papA) that encodes a ases and tripeptidases and finally by carboxypeptidases prolyl aminopeptidase from Aspergillus niger. Homolo- and aminopeptidases. The turnover of proteins by pro- gous genes are present in the genomes of the Eurotiales teases provides a ready pool of amino acids as precur- A. nidulans, A. fumigatus and Talaromyces emersonii, sors for the synthesis of new proteins (Bennet and Klich but the gene is not present in the genome of the yeast 1992). Saccharomyces cerevisiae. Cell extracts of strains over- Proteases normally do not hydrolyse bonds adjacent expressing the gene under the control of its own pro- to proline residues. Instead a specialised group of en- moter showed a fourfold to sixfold increase in prolyl zymes has evolved that hydrolyses these bonds. Their aminopeptidase activity, but no change in phenylalanine activity depends on both the isomeric state of the proline or leucine aminopeptidase activity. The overexpressed residue and its position in the peptide chain (Vanhoof enzyme was subsequently purified and characterised. et al. 1995; Cunningham and O’Connor 1997). Proline The enzyme specifically removes N-terminal proline and aminopeptidases (Pap, prolyl iminopeptidase, EC hydroxyproline residues from peptides.
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Supplemental Methods
    Supplemental Methods: Sample Collection Duplicate surface samples were collected from the Amazon River plume aboard the R/V Knorr in June 2010 (4 52.71’N, 51 21.59’W) during a period of high river discharge. The collection site (Station 10, 4° 52.71’N, 51° 21.59’W; S = 21.0; T = 29.6°C), located ~ 500 Km to the north of the Amazon River mouth, was characterized by the presence of coastal diatoms in the top 8 m of the water column. Sampling was conducted between 0700 and 0900 local time by gently impeller pumping (modified Rule 1800 submersible sump pump) surface water through 10 m of tygon tubing (3 cm) to the ship's deck where it then flowed through a 156 µm mesh into 20 L carboys. In the lab, cells were partitioned into two size fractions by sequential filtration (using a Masterflex peristaltic pump) of the pre-filtered seawater through a 2.0 µm pore-size, 142 mm diameter polycarbonate (PCTE) membrane filter (Sterlitech Corporation, Kent, CWA) and a 0.22 µm pore-size, 142 mm diameter Supor membrane filter (Pall, Port Washington, NY). Metagenomic and non-selective metatranscriptomic analyses were conducted on both pore-size filters; poly(A)-selected (eukaryote-dominated) metatranscriptomic analyses were conducted only on the larger pore-size filter (2.0 µm pore-size). All filters were immediately submerged in RNAlater (Applied Biosystems, Austin, TX) in sterile 50 mL conical tubes, incubated at room temperature overnight and then stored at -80oC until extraction. Filtration and stabilization of each sample was completed within 30 min of water collection.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Changes in the Sclerotinia Sclerotiorum Transcriptome During Infection of Brassica Napus
    Seifbarghi et al. BMC Genomics (2017) 18:266 DOI 10.1186/s12864-017-3642-5 RESEARCHARTICLE Open Access Changes in the Sclerotinia sclerotiorum transcriptome during infection of Brassica napus Shirin Seifbarghi1,2, M. Hossein Borhan1, Yangdou Wei2, Cathy Coutu1, Stephen J. Robinson1 and Dwayne D. Hegedus1,3* Abstract Background: Sclerotinia sclerotiorum causes stem rot in Brassica napus, which leads to lodging and severe yield losses. Although recent studies have explored significant progress in the characterization of individual S. sclerotiorum pathogenicity factors, a gap exists in profiling gene expression throughout the course of S. sclerotiorum infection on a host plant. In this study, RNA-Seq analysis was performed with focus on the events occurring through the early (1 h) to the middle (48 h) stages of infection. Results: Transcript analysis revealed the temporal pattern and amplitude of the deployment of genes associated with aspects of pathogenicity or virulence during the course of S. sclerotiorum infection on Brassica napus. These genes were categorized into eight functional groups: hydrolytic enzymes, secondary metabolites, detoxification, signaling, development, secreted effectors, oxalic acid and reactive oxygen species production. The induction patterns of nearly all of these genes agreed with their predicted functions. Principal component analysis delineated gene expression patterns that signified transitions between pathogenic phases, namely host penetration, ramification and necrotic stages, and provided evidence for the occurrence of a brief biotrophic phase soon after host penetration. Conclusions: The current observations support the notion that S. sclerotiorum deploys an array of factors and complex strategies to facilitate host colonization and mitigate host defenses. This investigation provides a broad overview of the sequential expression of virulence/pathogenicity-associated genes during infection of B.
    [Show full text]
  • Isolation and Characterization of the Prolyl Aminopeptidase Gene (Pap) from Aeromonas Sobria: Comparison with the Bacillus Coagulans Enzyme1
    J. Biochem. 116, 818-825 (1994) Isolation and Characterization of the Prolyl Aminopeptidase Gene (pap) from Aeromonas sobria: Comparison with the Bacillus coagulans Enzyme1 Ana Kitazono,* Atsuko Kitano,* Daisuke Tsuru,•õ and Tadashi Yoshimoto*,2 *School of Pharmaceutical Sciences , Nagasaki University, 1-14 Bunkyo-machi, Nagasaki, Nagasaki 852; and •õ Department of Applied Microbiology, Kumamoto Institute of Technology, 4-22-1 Ikeda, Kumamoto, Kumamoto 860 Received for publication, May 16, 1994 The Aeromonas sobria pap gene encoding prolyl aminopeptidase (PAP) was cloned. It consists of 425 codons and encodes a homotetrameric enzyme of 205kDa. The purified enzyme showed an almost absolute specificity for amino-terminal proline. Proline and hydroxyproline residues from many peptide and amide substrates could be easily removed, while no activity was detected for substrates having other amino terminals. The enzyme was very similar to that from Bacillus coagulans in many aspects, such as the strong inhibition caused by PCMB and the weak or no inhibition caused by DFP and chelators, respectively. However, these enzymes show only 15% identity in their amino acid sequences. Differences were also observed in their molecular weight, stability and activity toward some peptide substrates. When aligning the deduced amino acid sequence with known sequences from other microorganisms, conserved sequences were found at the amino-terminal region; the significance of these conserved regions is discussed. Based on the results of this work, and on the studies available to date, the occurrence of at least two types of PAPs is postulated. One group would be formed by the Bacillus, Neisseria, and Lactobacillus enzymes, and the other by enzymes such as the Aeromonas PAP.
    [Show full text]
  • REVIEW ARTICLE High Molecular Mass Intracellular Proteases
    Biochem J. (1989) 263, 625-633 (Printed in Great Britain) 625 REVIEW ARTICLE High molecular mass intracellular proteases A. Jennifer RIVETT Department of Biochemistry, University of Leicester, Leicester LE'l 7RH, U.K. INTRODUCTION demonstrated that intracellular proteolysis is not re- Many of the well-characterized proteolytic enzymes, stricted to the lysosomes. Since a large proportion of and particularly those for which X-ray structures are intracellular protein breakdown, especially the degra- now available, are small monomeric enzymes often dation of proteins with short half-lives, is now known to having molecular masses in the range of 20-30 kDa. occur by nonlysosomal mechanisms (Mayer & Doherty, Many of them are extracellular enzymes which are easy 1986; Bond & Beynon, 1987; Rechsteiner, 1987; Bohley, to assay and to purify. With a growing awareness of the 1987; Rivett, 1989b; Katunuma & Kominami, 1989; importance of intracellular protein turnover and Knecht & Grisolia, 1989), there is now a greater interest mechanisms of intracellular protein breakdown, interest in nonlysosomal degradation systems and in nonlyso- in the proteases responsible has also increased. Although somal proteinases, many of which have large complex some intracellular proteases, especially those found structures. within the lysosomes in animal cells, are, like extracellular In contrast to the well-known lysosomal proteases, proteases, small and highly active monomeric enzymes, soluble extralysosomal proteases often have multimeric a number of cellular proteases
    [Show full text]
  • Reticulum-Resident Peptidases Activities of Cytosolic And
    The Efficiency of Human Cytomegalovirus pp65 495−503 CD8+ T Cell Epitope Generation Is Determined by the Balanced Activities of Cytosolic and Endoplasmic This information is current as Reticulum-Resident Peptidases of September 30, 2021. Sabrina Urban, Kathrin Textoris-Taube, Barbara Reimann, Katharina Janek, Tanja Dannenberg, Frédéric Ebstein, Christin Seifert, Fang Zhao, Jan H. Kessler, Anne Halenius, Petra Henklein, Julia Paschke, Sandrine Cadel, Helga Downloaded from Bernhard, Ferry Ossendorp, Thierry Foulon, Dirk Schadendorf, Annette Paschen and Ulrike Seifert J Immunol published online 15 June 2012 http://www.jimmunol.org/content/early/2012/06/15/jimmun ol.1101886 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2012/06/15/jimmunol.110188 Material 6.DC1 Why The JI? Submit online. by guest on September 30, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright
    [Show full text]
  • Studies of Structure and Function of Tripeptidyl-Peptidase II
    Till familj och vänner List of Papers This thesis is based on the following papers, which are referred to in the text by their Roman numerals. I. Eriksson, S.; Gutiérrez, O.A.; Bjerling, P.; Tomkinson, B. (2009) De- velopment, evaluation and application of tripeptidyl-peptidase II se- quence signatures. Archives of Biochemistry and Biophysics, 484(1):39-45 II. Lindås, A-C.; Eriksson, S.; Josza, E.; Tomkinson, B. (2008) Investiga- tion of a role for Glu-331 and Glu-305 in substrate binding of tripepti- dyl-peptidase II. Biochimica et Biophysica Acta, 1784(12):1899-1907 III. Eklund, S.; Lindås, A-C.; Hamnevik, E.; Widersten, M.; Tomkinson, B. Inter-species variation in the pH dependence of tripeptidyl- peptidase II. Manuscript IV. Eklund, S.; Kalbacher, H.; Tomkinson, B. Characterization of the endopeptidase activity of tripeptidyl-peptidase II. Manuscript Paper I and II were published under maiden name (Eriksson). Reprints were made with permission from the respective publishers. Contents Introduction ..................................................................................................... 9 Enzymes ..................................................................................................... 9 Enzymes and pH dependence .............................................................. 11 Peptidases ................................................................................................. 12 Serine peptidases ................................................................................. 14 Intracellular protein
    [Show full text]
  • Supplementary Table 3 Gene Microarray Analysis: PRL+E2 Vs
    Supplementary Table 3 Gene microarray analysis: PRL+E2 vs. control ID1 Field1 ID Symbol Name M Fold P Value 69 15562 206115_at EGR3 early growth response 3 2,36 5,13 4,51E-06 56 41486 232231_at RUNX2 runt-related transcription factor 2 2,01 4,02 6,78E-07 41 36660 227404_s_at EGR1 early growth response 1 1,99 3,97 2,20E-04 396 54249 36711_at MAFF v-maf musculoaponeurotic fibrosarcoma oncogene homolog F 1,92 3,79 7,54E-04 (avian) 42 13670 204222_s_at GLIPR1 GLI pathogenesis-related 1 (glioma) 1,91 3,76 2,20E-04 65 11080 201631_s_at IER3 immediate early response 3 1,81 3,50 3,50E-06 101 36952 227697_at SOCS3 suppressor of cytokine signaling 3 1,76 3,38 4,71E-05 16 15514 206067_s_at WT1 Wilms tumor 1 1,74 3,34 1,87E-04 171 47873 238623_at NA NA 1,72 3,30 1,10E-04 600 14687 205239_at AREG amphiregulin (schwannoma-derived growth factor) 1,71 3,26 1,51E-03 256 36997 227742_at CLIC6 chloride intracellular channel 6 1,69 3,23 3,52E-04 14 15038 205590_at RASGRP1 RAS guanyl releasing protein 1 (calcium and DAG-regulated) 1,68 3,20 1,87E-04 55 33237 223961_s_at CISH cytokine inducible SH2-containing protein 1,67 3,19 6,49E-07 78 32152 222872_x_at OBFC2A oligonucleotide/oligosaccharide-binding fold containing 2A 1,66 3,15 1,23E-05 1969 32201 222921_s_at HEY2 hairy/enhancer-of-split related with YRPW motif 2 1,64 3,12 1,78E-02 122 13463 204015_s_at DUSP4 dual specificity phosphatase 4 1,61 3,06 5,97E-05 173 36466 227210_at NA NA 1,60 3,04 1,10E-04 117 40525 231270_at CA13 carbonic anhydrase XIII 1,59 3,02 5,62E-05 81 42339 233085_s_at OBFC2A oligonucleotide/oligosaccharide-binding
    [Show full text]